GAG
CYTK icon

Goodman Advisory Group’s Cytokinetics CYTK Stock Holding History

Goodman Advisory Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-52
Closed -$2.86K – 187
2025
Q3 		$2.86K Buy
+52
New +$2.14K ﹤0.01% 167
2025
Q2 		– Sell
-600
Closed -$24.1K – 159
2025
Q1 		$24.1K Buy
+600
New +$27.6K 0.01% 127
2024
Q4 		– Sell
-600
Closed -$31.7K – 83
2024
Q3 		$31.7K Hold
600
– – 0.01% 130
2024
Q2 		$32.5K Hold
600
– – 0.01% 122
2024
Q1 		$42.1K Hold
600
– – 0.01% 101
2023
Q4 		$50.1K Hold
600
– – 0.02% 95
2023
Q3 		$17.7K Hold
600
– – 0.01% 116
2023
Q2 		$19.6K Hold
600
– – 0.01% 106
2023
Q1 		$21.1K Hold
600
– – 0.01% 96
2022
Q4 		$27K Hold
600
– – 0.02% 89
2022
Q3 		$29K Hold
600
– – 0.02% 88
2022
Q2 		$24K Buy
+600
New +$24.2K 0.01% 93

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return